Top section
Top section
New equity capital markets talent and Bernstein joint venture have helped Société Générale win eye-catching mandates. Next, it will expand sector teams
BNPP is rebuilding strength in advisory in France
I thought the grass would be greener in fintech land, but it’s patchy and dreary
More articles
More articles
More articles
-
Private equity firms are looking at different ways of monetising their investments, rather than the usual IPO routes, as regulation makes smaller firms less viable in the public markets. Alternative capital providers outside the usual buyout community are also boosting their allocations to private assets. -
Vivo Energy, the pan-African fuel distributor, has added Numis Securities to its corporate broking roster.
-
Zero-E the company that holds the wind, solar and thermal assets of Actividades de Construcción y Servicios has found a private buyer for its Spanish renewables assets, making an IPO unlikely.
-
There was a burst of activity from Chinese pharmaceutical and biotechnology companies in the equity capital markets this week, as the sector took centre stage following the spread of a flu-like virus that has already claimed lives on the mainland. Jonathan Breen reports.
-
Sino Biopharmaceutical issued a zero coupon convertible bond on Wednesday, boosting the size to €750m as demand poured in from across Asia, Europe and the US, according to multiple sources close to the deal.
-
A trade in Orpéa that mixed an auctioned block trade with a wall-crossing process left equity capital markets players bristling this week. But while some bankers disliked the method of bank selection, others told Sam Kerr and Aidan Gregory that the process worked for the issuer and investors.
Sub-sections
shared comment list
